Vincent Wei-Tsin Li, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Angiogenesis Inducing Agents | 3 | 2011 | 278 | 0.560 |
Why?
|
| Platelet-Derived Growth Factor | 4 | 2011 | 617 | 0.400 |
Why?
|
| Angiogenesis Inhibitors | 4 | 2012 | 2047 | 0.350 |
Why?
|
| Leg Dermatoses | 1 | 2009 | 20 | 0.330 |
Why?
|
| Necrobiosis Lipoidica | 1 | 2009 | 14 | 0.330 |
Why?
|
| Aminoquinolines | 2 | 2008 | 108 | 0.330 |
Why?
|
| Adjuvants, Immunologic | 3 | 2008 | 1038 | 0.320 |
Why?
|
| Cellulose, Oxidized | 1 | 2007 | 12 | 0.300 |
Why?
|
| Biological Dressings | 1 | 2007 | 30 | 0.300 |
Why?
|
| Wound Healing | 5 | 2011 | 2783 | 0.280 |
Why?
|
| Oryzias | 3 | 2012 | 20 | 0.260 |
Why?
|
| Zebrafish | 7 | 2012 | 2993 | 0.220 |
Why?
|
| Collagen | 3 | 2011 | 2635 | 0.190 |
Why?
|
| Neovascularization, Physiologic | 3 | 2011 | 1332 | 0.180 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 1793 | 0.170 |
Why?
|
| Wounds and Injuries | 2 | 2011 | 2476 | 0.160 |
Why?
|
| Fibroblast Growth Factor 2 | 3 | 2011 | 590 | 0.150 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 4342 | 0.150 |
Why?
|
| Dermatologic Agents | 2 | 2011 | 308 | 0.140 |
Why?
|
| Tuberculin Test | 1 | 1997 | 206 | 0.140 |
Why?
|
| Drug Delivery Systems | 1 | 2008 | 2212 | 0.130 |
Why?
|
| Water Pollutants, Chemical | 2 | 2012 | 354 | 0.130 |
Why?
|
| Drug Labeling | 1 | 1998 | 248 | 0.130 |
Why?
|
| Neovascularization, Pathologic | 2 | 2020 | 2638 | 0.120 |
Why?
|
| BCG Vaccine | 1 | 1997 | 371 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2009 | 3432 | 0.120 |
Why?
|
| Zebrafish Proteins | 2 | 2010 | 1006 | 0.110 |
Why?
|
| Leptin | 2 | 2012 | 1591 | 0.110 |
Why?
|
| Embryo, Nonmammalian | 3 | 2012 | 900 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 1 | 2009 | 9160 | 0.100 |
Why?
|
| Bandages, Hydrocolloid | 1 | 2011 | 8 | 0.100 |
Why?
|
| Drug Approval | 1 | 1998 | 808 | 0.100 |
Why?
|
| Carboxymethylcellulose Sodium | 1 | 2011 | 38 | 0.090 |
Why?
|
| Angiogenic Proteins | 1 | 2011 | 101 | 0.090 |
Why?
|
| Propranolol | 1 | 2012 | 489 | 0.090 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 1997 | 831 | 0.090 |
Why?
|
| Pyoderma Gangrenosum | 1 | 2011 | 84 | 0.090 |
Why?
|
| Skin Physiological Phenomena | 1 | 2011 | 188 | 0.090 |
Why?
|
| Chemoprevention | 1 | 2012 | 326 | 0.090 |
Why?
|
| Skin Diseases | 1 | 1998 | 1088 | 0.090 |
Why?
|
| Receptor, Muscarinic M2 | 1 | 2009 | 15 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2011 | 3480 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2012 | 3602 | 0.080 |
Why?
|
| Materia Medica | 1 | 2008 | 14 | 0.080 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2009 | 240 | 0.080 |
Why?
|
| Skin Neoplasms | 1 | 2008 | 5797 | 0.080 |
Why?
|
| Egg Proteins | 1 | 2007 | 57 | 0.080 |
Why?
|
| Endothelium, Vascular | 1 | 2020 | 4429 | 0.070 |
Why?
|
| Fish Proteins | 1 | 2007 | 47 | 0.070 |
Why?
|
| Heart | 2 | 2012 | 4382 | 0.070 |
Why?
|
| Bradycardia | 1 | 2009 | 299 | 0.070 |
Why?
|
| Achilles Tendon | 1 | 2010 | 179 | 0.070 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2008 | 145 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2007 | 255 | 0.070 |
Why?
|
| Thrombosis | 1 | 2020 | 2929 | 0.070 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2005 | 97 | 0.060 |
Why?
|
| Tensile Strength | 3 | 2011 | 330 | 0.060 |
Why?
|
| Skin Care | 1 | 2005 | 57 | 0.060 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2011 | 1111 | 0.060 |
Why?
|
| Retinal Ganglion Cells | 1 | 2010 | 806 | 0.060 |
Why?
|
| Infusions, Intravenous | 1 | 2009 | 2210 | 0.060 |
Why?
|
| Thrombospondin 1 | 1 | 2005 | 257 | 0.060 |
Why?
|
| Apoptosis | 3 | 2012 | 9468 | 0.060 |
Why?
|
| Protein Precursors | 1 | 2007 | 1133 | 0.050 |
Why?
|
| Heart Rate | 2 | 2012 | 4166 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2010 | 1651 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3076 | 0.050 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2005 | 632 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3196 | 0.050 |
Why?
|
| Embryonic Stem Cells | 1 | 2009 | 1262 | 0.050 |
Why?
|
| Regeneration | 1 | 2011 | 1505 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2010 | 2413 | 0.050 |
Why?
|
| Estrogens | 1 | 2007 | 1520 | 0.050 |
Why?
|
| Gene Transfer Techniques | 1 | 2005 | 1203 | 0.040 |
Why?
|
| Nerve Regeneration | 1 | 2005 | 790 | 0.040 |
Why?
|
| Retina | 1 | 2010 | 2635 | 0.040 |
Why?
|
| Fibroblast Growth Factors | 1 | 2005 | 867 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2005 | 2904 | 0.040 |
Why?
|
| Dermatitis | 1 | 1999 | 200 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2005 | 4113 | 0.030 |
Why?
|
| Autopsy | 1 | 2020 | 1003 | 0.030 |
Why?
|
| Skin | 3 | 2011 | 4464 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2010 | 12759 | 0.030 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 447 | 0.030 |
Why?
|
| Hypersensitivity, Delayed | 1 | 1997 | 490 | 0.030 |
Why?
|
| Erythema | 1 | 1997 | 262 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2005 | 1870 | 0.030 |
Why?
|
| Animals | 13 | 2012 | 167768 | 0.030 |
Why?
|
| Blood Platelets | 1 | 2005 | 2475 | 0.030 |
Why?
|
| Liver | 1 | 2010 | 7502 | 0.030 |
Why?
|
| Software | 1 | 2008 | 4415 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4567 | 0.030 |
Why?
|
| Edema | 1 | 1997 | 768 | 0.030 |
Why?
|
| Humans | 14 | 2020 | 758406 | 0.030 |
Why?
|
| Fenretinide | 1 | 2012 | 9 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2005 | 3533 | 0.030 |
Why?
|
| Stem Cells | 1 | 2005 | 3521 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 58683 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2008 | 7980 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2007 | 9267 | 0.030 |
Why?
|
| Cloning, Molecular | 2 | 2008 | 4169 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2011 | 6209 | 0.020 |
Why?
|
| Respiratory Insufficiency | 1 | 2020 | 1230 | 0.020 |
Why?
|
| Skin Temperature | 1 | 2011 | 96 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2010 | 12094 | 0.020 |
Why?
|
| Collagen Type III | 1 | 2011 | 91 | 0.020 |
Why?
|
| Thermography | 1 | 2011 | 62 | 0.020 |
Why?
|
| Exudates and Transudates | 1 | 2011 | 174 | 0.020 |
Why?
|
| Cytokines | 1 | 2005 | 7338 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 1998 | 1659 | 0.020 |
Why?
|
| Patents as Topic | 1 | 2011 | 111 | 0.020 |
Why?
|
| Adrenergic beta-2 Receptor Antagonists | 1 | 2009 | 12 | 0.020 |
Why?
|
| Alpha Particles | 1 | 2009 | 29 | 0.020 |
Why?
|
| Animal Structures | 1 | 2009 | 24 | 0.020 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2009 | 51 | 0.020 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 1 | 2009 | 30 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2011 | 677 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 2012 | 13591 | 0.020 |
Why?
|
| Carbachol | 1 | 2009 | 223 | 0.020 |
Why?
|
| Neoplasms | 2 | 2012 | 22032 | 0.020 |
Why?
|
| Influenza, Human | 1 | 2020 | 1516 | 0.020 |
Why?
|
| Antitubercular Agents | 1 | 1997 | 1373 | 0.020 |
Why?
|
| Rupture | 1 | 2010 | 443 | 0.020 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2009 | 213 | 0.020 |
Why?
|
| Water Pollution | 1 | 2007 | 33 | 0.020 |
Why?
|
| DNA Primers | 1 | 2012 | 2816 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2009 | 881 | 0.020 |
Why?
|
| Sutures | 1 | 2010 | 293 | 0.020 |
Why?
|
| Larva | 1 | 2009 | 507 | 0.020 |
Why?
|
| Norepinephrine | 1 | 2009 | 897 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2009 | 459 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2008 | 13447 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2010 | 611 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2010 | 769 | 0.020 |
Why?
|
| Female | 7 | 2020 | 390323 | 0.020 |
Why?
|
| Risk Factors | 2 | 2005 | 73809 | 0.020 |
Why?
|
| Blood Vessels | 1 | 2011 | 1112 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 17617 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2011 | 2020 | 0.020 |
Why?
|
| Biological Assay | 1 | 2007 | 626 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2008 | 23342 | 0.010 |
Why?
|
| Metformin | 1 | 2012 | 907 | 0.010 |
Why?
|
| Autophagy | 1 | 2012 | 1322 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2011 | 1317 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2007 | 1991 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2008 | 2176 | 0.010 |
Why?
|
| Rabbits | 1 | 2010 | 4772 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2009 | 1240 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2011 | 64378 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 2269 | 0.010 |
Why?
|
| Lung | 1 | 2020 | 9985 | 0.010 |
Why?
|
| Base Sequence | 1 | 2012 | 12436 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2010 | 6234 | 0.010 |
Why?
|
| Radiation Dosage | 1 | 2009 | 1956 | 0.010 |
Why?
|
| Gene Expression Regulation | 2 | 2010 | 11892 | 0.010 |
Why?
|
| Aspirin | 1 | 2012 | 3131 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8611 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2012 | 3069 | 0.010 |
Why?
|
| Factitious Disorders | 1 | 1999 | 39 | 0.010 |
Why?
|
| Mice | 3 | 2011 | 81101 | 0.010 |
Why?
|
| Massachusetts | 1 | 2011 | 8823 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 5779 | 0.010 |
Why?
|
| Male | 5 | 2020 | 358747 | 0.010 |
Why?
|
| Comorbidity | 1 | 2011 | 10495 | 0.010 |
Why?
|
| Gene Expression | 1 | 2009 | 7583 | 0.010 |
Why?
|
| Myocardium | 1 | 2009 | 4690 | 0.010 |
Why?
|
| Internet | 1 | 2008 | 3082 | 0.010 |
Why?
|
| Disease Progression | 1 | 2012 | 13468 | 0.010 |
Why?
|
| Aged | 2 | 2020 | 168218 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2010 | 9574 | 0.010 |
Why?
|
| Self-Injurious Behavior | 1 | 1999 | 556 | 0.010 |
Why?
|
| Inflammation | 1 | 2012 | 10718 | 0.010 |
Why?
|
| Adult | 3 | 2011 | 219935 | 0.010 |
Why?
|
| Middle Aged | 2 | 2020 | 219568 | 0.010 |
Why?
|
| United States | 1 | 1998 | 72136 | 0.010 |
Why?
|
| Time Factors | 1 | 2008 | 39872 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 2002 | 7985 | 0.000 |
Why?
|
| Young Adult | 1 | 2011 | 58808 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1999 | 12951 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2011 | 80168 | 0.000 |
Why?
|
| Brain | 1 | 2009 | 26947 | 0.000 |
Why?
|